Cipher Pharmaceuticals

192 articles with Cipher Pharmaceuticals

• Cipher Pharma Out-Licenses Rights To ASF-1096 For Anorectal Disorders

  6/20/2016

• Cipher Pharma To Present At Two Upcoming U.S. Investor Conferences

  5/31/2016

• Cipher Pharma Reports Voting Results From Annual And Special Meeting Of Shareholders

  5/6/2016

• Cipher Pharma Reports Q1 2016 Financial Results

  5/5/2016

• Cipher Pharma Acquires Worldwide Rights To Dalhousie University's Investigational Tattoo Removal Cream

  5/2/2016

• Notice Of Cipher Pharma Q1 2016 Conference Call & Annual And Special Meeting

  4/25/2016

• Cipher Pharma Announces Retirement Of CFO Norm Evans

  4/22/2016

• Cipher Pharma Proposes Adding Rosemary A. Crane And Dr. Renee P. Tannenbaum To Board Of Directors

  4/7/2016

• Cipher Pharma Announces Approvals Of Astion Acquired Barrier Creams By Health Canada And The Medicines Evaluation Board

  4/7/2016

• Cipher Pharma Announces Canadian Launch Of Beteflam

  4/6/2016

• Cipher Pharma Appoints Ralph Bohrer President & General Manager Of U.S. Business

  3/4/2016

• Cipher Pharma To Present At Two Upcoming Investor Conferences

  3/3/2016

• Cipher Pharma Reports 2015 Financial Results

  2/24/2016

• Cipher Pharma Announces Canadian Launch Of Actikerall

  2/22/2016

• Cipher Pharma Launches A Foam Preparation Of Bionect

  2/17/2016

• Cipher Pharma Announces Sitavig Accepted For Review By Health Canada

  2/16/2016

• Notice Of Cipher Pharma Q4 And Year-End 2015 Conference Call

  2/9/2016

• Cipher Pharma Receives Health Canada Approval Of (Pr)Beteflam

  12/7/2015

• Cipher Pharma To Present At Piper Jaffray Healthcare Conference 2015

  11/25/2015

• Cipher Pharma Reports Third Quarter Results

  11/4/2015